‹ BackHN Continuity

Thread

Claude discovers a novel enzyme system with CRISPR-like repeats

780 points · 805 comments · raahelb

  1. AbstractH24 · · focus · HN ↗
    I recently heard Anthropic quietly setup its own bio lab.

    That it’s plausible that they’ll move from selling tokens as their primary source of revenue to building frontier models to do cutting edge research, and using the research as their primary source of revenue rather than release the models. Because it’ll be far less of a race to the bottom than commodified tokens used by the general public.

    Will be interesting to see how this all unfolds. (No pun intended, but there is a funny one there…)

    1. preommr · · focus · HN ↗
      Yea, I think that there's pretty much a ceiling with day-to-day models that have already been hit months ago. Maybe you need SOTA for reviews, high-level planning, or research, but long running tasks like writing out a feature, testing, getting feedback and making refactors can be done for low-end models (like luna). And the margins on those models are basically evaporating.
Open on Hacker News to reply ↗

Unofficial Hacker News client; not affiliated with Y Combinator.